Argan, Inc. (AGX)
NYSEIndustrialsEngineering & ConstructionSnapshot 2026-10-30
$344.11-3.57%
Close 2026-10-30 · 1-day change
NYSEIndustrialsEngineering & ConstructionSnapshot 2026-10-30
Research Workspace
Put AGX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Construction & Engineering is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 29% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 20%.
View QualityManagement screens strong on capital allocation, earnings delivery.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 3% on a typical day and fell roughly 59% in its worst 12-month stretch.
View RiskAGX’s bet rests on strong recent performance, despite Mania, sector headwinds, and elevated risk. Revenue growth accelerated from 50.2% to 61.5% year over year, with both quarters beating. AGX trades at 28× P/E versus a 40× peer median and its own 35× history. The price reflects less growth than our forecast, though overvaluation concerns challenge confidence. A next-quarter earnings miss probability near 19% is another risk. Peer multiples imply a price about 27% above where it trades. Our read remains intact; this read is provisional.
Trailing returns as of 2026-10-30. AGX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 6 analysts currently covering AGX (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare AGX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| AGX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Construction & Engineering — fair value, gap to price, and forward P/E.
Compare the value case
Put AGX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Overvaluation concerns could impact investor confidence and stock price.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Improve operating income and profitability
Margin issues could hinder profitability improvements.
Overvaluation concerns could impact investor confidence and stock price.
Advances: Increase revenue through project backlog
Q2 earnings beat supports revenue growth objective.
Advances: Increase revenue through project backlog
Record revenue supports growth through project backlog.
Advances: Increase revenue through project backlog
New projects support revenue growth objective.
Advances: Increase revenue through project backlog
Earnings beat indicates strong project backlog growth.
Advances: Improve operating income
Margin boost indicates improved operating income potential.
